List of Treatments for Pulmonary Hypertension

Below is a listing of treatments and therapies for pulmonary hypertension. Click on one to read more information or connect with others currently using it.

Nutrition

Overview
Like everyone else, people with pulmonary hypertension (PH) feel their best when they consistently eat a healthy, balanced diet. By choosing the right foods, people with PH can improve disease symptoms and… read more

Opsumit (Macitentan)

Overview
Opsumit is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to delay disease progression in cases of pulmonary arterial hypertension (PAH). Opsumit may be referred to by its drug… read more

Opsynvi (Macitentan and Tadalafil)

Overview
Opsynvi, approved by the U.S. Food and Drug Administration (FDA), is indicated for the chronic treatment of adults with pulmonary arterial hypertension (PAH, WHO group 1) at WHO functional class 2 and 3…

Orenitram (Treprostinil)

Overview
Orenitram is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to improve exercise capacity in cases of pulmonary arterial hypertension (PAH). Orenitram may be referred to by its drug… read more

Oxygen therapy

Overview
People with pulmonary hypertension caused by conditions such as chronic obstructive pulmonary disease (COPD), interstitial lung disease, and sleep apnea may develop hypoxia, or low levels of oxygen in the… read more

Procardia (Nifedipine)

The Procardia brand name has been discontinued in the U.S. Generic alternatives may be available.

Overview

Procardia is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to manage vasospastic…

Procardia XL (Nifedipine)

Overview
Procardia XL is approved by the U.S. Food and Drug Administration (FDA) for the treatment of vasospastic angina (chest pain due to spasms in the coronary arteries), chronic stable angina, and hypertension (high…

Pulmonary rehabilitation

Overview
People with pulmonary hypertension (PH) may develop shortness of breath that makes it difficult to walk and perform other daily activities. Pulmonary rehabilitation is a program designed to improve your ability… read more

Pulmonary thromboendarterectomy (PTE)

Overview
Pulmonary thromboendarterectomy (PTE) surgery is a potential cure for some people with chronic thromboembolic pulmonary hypertension (CTEPH). CTEPH is a type of pulmonary hypertension wherein blood clots in… read more

Remodulin (Treprostinil)

Overview
Remodulin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to improve exercise capacity in cases of pulmonary arterial hypertension (PAH). Remodulin is sometimes prescribed when… read more

Revatio (Sildenafil)

Overview
Revatio is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to improve exercise and delay disease progression in cases of pulmonary arterial hypertension. Revatio may be referred to… read more

Tadliq (Tadalafil)

Overview
Tadliq is approved by the U.S. Food and Drug Administration (FDA) for the treatment of pulmonary arterial hypertension (PAH) Group 1. It is prescribed to improve exercise ability in individuals with PAH. Tadliq…

Tracleer (Bosentan)

Overview
Tracleer is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to improve exercise capacity and limit disease progression in adults with pulmonary arterial hypertension (PAH). Tracleer… read more

Tyvaso (Treprostinil)

Overview
Tyvaso is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to improve exercise capacity in cases of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with… read more

Uptravi (Selexipag)

Overview
Uptravi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to delay disease progression and reduce the risk of hospitalization in cases of pulmonary arterial hypertension (PAH).… read more

Veletri (Epoprostenol)

Overview
Veletri is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to improve exercise capacity in cases of pulmonary arterial hypertension (PAH). Veletri may be referred to by its drug… read more

Ventavis (Iloprost)

Overview
Ventavis is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to improve symptoms and exercise capacity and to avoid deterioration in cases of pulmonary arterial hypertension (PAH).… read more

Winrevair (Sotatercept-csrk)

Overview
Winrevair is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with pulmonary arterial hypertension (PAH, World Health Organization group 1). It is used to help increase exercise…

Yutrepia (Treprostinil)

Overview
Yutrepia is approved by the U.S. Food and Drug Administration (FDA) for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. It is prescribed to…

Connect with others who understand.